La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Greenlane Hldgs a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Greenlane Hldgs..

Greenlane Hldgs (NASDAQ:GNLN) Azioni, Catena delle Opzioni

Greenlane Hldgs

Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.

A frustrated millennial recently sparked a big conversation on Reddit after admitting she and her partner can't afford to buy a home or raise a child. She wrote in <a href="https://www.reddit.com/r/Millennials/comments/1lzby95/i_dont_understand_how_other_millennials_are/">r/Millennials</a> recently, "I don&#8217;t understand how other millennials are affording their lives. It has to be <a href="https://www.benzinga.com/personal-finance/25/03/44235244/inheritance-boom-the-6t-windfall-reshaping-wealth-in-2025">inheritance money</a> or credit card debt. Right? I don't understand how anyone bought a house recently or is raising a child right now."
<h2 class="wp-block-heading">Pre-COVID Homebuyers Say Timing Was Everything</h2>
Hundreds of fellow millennials jumped in to explain how they managed or didn't. An unmistakable pattern emerged: those who bought homes before the pandemic are in a far better place than those trying to enter the market today.
Don't Miss:
<ul class="wp-block-list">
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
<li>$100k+ in investable assets? <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes</a> – no cost, no obligation.</li>
</ul>
"We purchased our house pre-COVID," one person wrote. "We <a href="https://www.benzinga.com/markets/25/02/43818622/buying-just-keeps-getting-more-expensive-study-shows-home-prices-up-in-89-of-us-cities-in-2024">couldn&#8217;t afford to buy it now</a>, or literally any house now." Another added, "I was lucky enough to snag a house pre-COVID with a moderate, single income. I sold it five years later for almost double what I paid for it. If I hadn't done that, we'd never be able to afford a house in our area."
Others pointed out how the cost of childcare is crushing those who try to do both. "<a href="https://www.benzinga.com/news/25/04/44999168/reason-people-dont-have-kids-earlier-is-theyre-expensive-says-kevin-oleary-however-time-is-the-one-thing-money-cant-buy">Kids still cost thousands</a> each month," one millennial said.&nbsp;
<h2 class="wp-block-heading">Privilege, Luck And Hard Choices</h2>
Some admitted they benefited from family support or tragic circumstances. One man shared that his house was paid off by a life insurance payout after his wife died. Another wrote, "Same sh&#x2A;t happened to me! Miss that asshole but yeah financially I'm great."
Then there were those who credited their success to smart timing and frugal living. "We both have state gov jobs, so we don&#8217;t need to plan as much for retirement," one person said. They also live really frugally during the week so that they can have fun on the weekend. "My car is electric, her commute is 11 minutes."
Trending: Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a>
<h2 class="wp-block-heading">Career Paths Made A Huge Difference</h2>
Many commenters pointed to lucrative careers in law, tech, finance and sales. One couple, ages 34 and 37, said their combined income is $480,000. "We didn't come from wealthy families," the woman explained. "I'm a lawyer for a Fortune 5 company. My husband is a senior sales manager in big tech, and their commission structure is generous."
Others weren't so lucky. "I'm 33, making $45K trying my damned hardest," one person wrote. Another said, "I wasn't making it until I went back to school at 30 years old."
Plenty pointed out the generational gap even within millennials themselves. "Millennials are like 30 to 45 now," one person noted. "You&#8217;re in a vastly different life if you&#8217;re a young millennial than an older one."
See Also: This AI-Powered Trading Platform Has 5,000+ Users, 27 Pending Patents, and a $43.97M Valuation — <a href="https://www.benzinga.com/money/finally-a-fully-automated-trading-platform-for-individual-investors?">You Can Become an Investor for Just $500.25</a>
<h2 class="wp-block-heading">Staying Afloat Without Inheritance Or Debt</h2>
Some said it came down to hard work, luck, and avoiding lifestyle inflation. One person wrote, "We live on less than we make. That's it. Purchased a home and have two kids. No inheritance."
Another added, &#8220;I own my older Volvo SUV and got my house around 12 years ago. I just happily ate a tomato I grew for dinner. That&#8217;s all. I&#8217;m easy to please.&#8221;
In the end, many agreed: timing, location, career choice and family support often make or break whether millennials can afford what used to be considered a standard middle-class life.
Read Next: <a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a>
Image: Shutterstock

Personal Finance

We Can't Afford A Kid Or A House, Says A Millennial. She's Baffled How Anyone Else Is Managing To Do Both Right Now

Roth Capital analyst Boobalan Pachaiyappan maintains Capricor Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPR#NASDAQ">CAPR</a>) with a Buy and lowers the price target from $31 to $12.

News

Price Target

Analyst Ratings

CAPR

Roth Capital Maintains Buy on Capricor Therapeutics, Lowers Price Target to $12

Barclays analyst Alex Scott initiates coverage on Slide Insurance Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLDE#NASDAQ">SLDE</a>) with a Overweight rating and announces Price Target of $25.

Initiation

SLDE

Barclays Initiates Coverage On Slide Insurance Holdings with Overweight Rating, Announces Price Target of $25

Although its risk-reward is fundamentally balanced, SoundHound AI Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) execution in the back half of the year "could create a <a href="https://www.benzinga.com/markets/tech/25/07/46303589/why-is-soundhound-stock-soaring-tuesday">squeeze on shares</a>," according to Piper Sandler.
The SoundHound AI Analyst: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5a09e167efacff00012b1912/james-fish">Analyst James Fish</a> downgraded the rating from Overweight to Neutral, while establishing a price target of $12.
The SoundHound AI Thesis: To meet its full-year guidance, the company needs a large ramp in the latter half of the year, which is challenging given the current environment, Fish said in the downgrade note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
While SoundHound AI has a very large market and its business is shifting fast towards the subscription model, there have been limited responses for standalone Voice AI vendors, the analyst stated.
A lot of customers are in the testing, rather than implementing, phase, which "could signal AI push-outs," he added.
The company needs to make investments in its Amelia platform, which makes achieving profitability very challenging, Fish added.
SOUN Price Action: SoundHound AI shares were down 4.32% at $11.07 at the time of publication on Monday, <a href="https://www.benzinga.com/pro/" target="_blank" rel="noreferrer noopener">according to Benzinga Pro</a>.
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/content/46344724/soundhound-rises-as-short-sellers-exit-and-ai-demand-grows">SoundHound Rises as Short Sellers Exit and AI Demand Grows</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Downgrades

Movers

SOUN

SoundHound Needs Big Year-End Push, Faces Execution Challenges

Transitioning to a four-day work week may be advantageous for employers as well as employees, a new <a href="https://6a142ff6-85bd-4a7b-bb3b-476b07b8f08d.usrfiles.com/ugd/6a142f_2118d61d48164545b31b9d9b792d8153.pdf">study</a> done in the UK by the 4 Day Week Foundation and Boston College finds.&nbsp;
The foundation, which advocates for shorter working hours, just released the findings of its latest national pilot program. Seventeen companies and over 950 employees took part in the six-month program, which cut the work week from 40 hours down to just 32 hours.
As you might have expected, the benefits of the change for employees were primarily positive. Almost half (47%) reported increased job satisfaction, while 62% said they experienced a reduction in burnout. Additionally, 45% of employees reported feeling more satisfied with life following the change, largely because they were experiencing better work-life balance.
Don't Miss:
<ul class="wp-block-list">
<li>Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a></li>
<li>Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a></li>
</ul>
What might shock you, however, is that several of the companies that participated in the program also reported that things improved for their businesses after they cut working hours.
Several organizations reported a decrease in the number of resignations over the course of the trial, when compared with a similar six-month period. Others said that they experienced a 30% drop in the number of sick and personal days taken over the course of the trial, when compared to the same six months the year before.
BrandPipe, a London-based software company, had some of the most significant results. The company dropped working hours for its employees from 35 to 28, and reported a 129.5% increase in revenue as well as a 100% reduction in the number of personal days taken by its employees.&nbsp;
Trending: $100k+ in investable assets? <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes</a> – no cost, no obligation.
"The trial's been an overwhelming success for BrandPipe because it has been the launchpad for us to consider what constitutes efficiency, progressive working practice, and the ability to focus on the things that really matter to our business and our customers," BrandPipe CEO Geoff Slaughter told researchers.
Slaughter was so enthusiastic about the results of the trial and the positive effects it had on the company that he encouraged other tech leaders to be open-minded about reducing their office hours. "[It's] a great thing for businesses to try," he told researchers. "The learnings that come out of it are kind of adjacent to the fact that you&#8217;ve reduced working hours."
Not everyone is as optimistic about the potential of four-day work weeks. King's College London public policy professor Michael Sanders told <a href="https://www.cnn.com/2025/07/03/business/four-day-week-trial-uk-intl">CNN</a> that trials like the one run by the 4 Day Week Foundation are self-selected and therefore conducted in companies where the change "would be taken up enthusiastically."
A shorter work week may work for them, but it "doesn't tell us much about what would happen if someone else tried it," he said.
Read Next:
<ul class="wp-block-list">
<li>This AI-Powered Trading Platform Has 5,000+ Users, 27 Pending Patents, and a $43.97M Valuation — <a href="https://www.benzinga.com/money/finally-a-fully-automated-trading-platform-for-individual-investors?">You Can Become an Investor for Just $500.25</a></li>
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
</ul>
Image: Shutterstock

Better Bottom Lines And Increased Employee Motivation: Why Some Are Calling The 4-Day Work Week 'A Great Thing For Businesses To Try'

JP Morgan analyst Jessica Fye maintains Vertex Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) with a Overweight and raises the price target from $515 to $517.

VRTX

JP Morgan Maintains Overweight on Vertex Pharmaceuticals, Raises Price Target to $517

Roth Capital analyst Rohit Kulkarni maintains DoorDash (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>) with a Neutral and raises the price target from $191 to $225.

DASH

Roth Capital Maintains Neutral on DoorDash, Raises Price Target to $225

Venture capital Fund 20VC founder Harry Stebbings made a LinkedIn post in June that sparked a debate among European tech leaders about the culture of overworking.
"What European founders need to realize: The valley has turned up the intensity once again. Seven days a week is the velocity required to win right now," the <a href="https://www.linkedin.com/posts/harrystebbings_founder-funding-business-activity-7334473729579606016-56Od/?utm_source=share&amp;amp;utm_medium=member_desktop&amp;amp;rcm=ACoAACdGTRUBsbnEwmIC4xyi31AUL8KI7DRHNoY">post</a> read. There is no room for slip up. You aren't competing against a random company in Germany, etc., but the best in the world,"&nbsp;
Like many LinkedIn posts, Stebbings intended his message to be motivational. However, it wound up being wildly controversial.
Don't Miss:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
<li>Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a></li>
</ul>
In places like China, the 996 work culture, where employees are expected to be at their desks from 9 a.m. to 9 p.m., six days a week, has been the expected mode of operation for years. CNBC has reported that at China-based companies like <a href="https://www.cnbc.com/2019/04/15/alibabas-jack-ma-working-overtime-is-a-huge-blessing.html">Alibaba</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) and <a href="https://www.cnbc.com/2021/05/06/tiktoks-toxic-culture-reviews-on-glassdoor-impact-hiring.html">TikTok</a> all but require 996 working hours from their employees.
However, many European founders and venture capitalist partners are now telling <a href="https://www.cnbc.com/2025/06/08/europe-startups-resists-pressure-to-adopt-chinas-996-work-culture.html">CNBC</a> that they think the 996 work culture is unnecessary.
"It's about a fetishization of overwork rather than smart work…it's a myth," Balderton Capital General Partner Suranga Chandratillake told CNBC. "California is very good at telling stories and there's a lot of mythmaking around the concept of what startups look like…. there is hard work involved but if you really spend time in that ecosystem, you will discover that lots of people work really hard, but there are also periods where they don't work."
Trending: $100k+ in investable assets? <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes</a> – no cost, no obligation.
Bloom Money founder Nina Mohanty agrees, pointing out the "lasting effects and unintended consequences" of such an over-the-top work culture.&nbsp;
Husmus co-founder Sarah Wernér and Bethnal Green Ventures Partner Dama Sathianathan pointed to the negative effects 996 work culture has on talent.&nbsp;
"Overwork today is a productivity crisis tomorrow," Wernér told CNBC. "Personally, I hope my competitors are doing 996. It makes poaching great people a lot easier when they decide they've had enough."
"Optimizing labor doesn't always lead to better productivity, or help with differentiating from other companies long-term, if you've made work devoid of meaning," Sathianathan explained.
Meanwhile, Luna founder Jas Schembri-Stothart said that 996 culture was going to alienate millennial and Gen Z employees, in particular, as they have "much less tolerance for toxic hustle culture."&nbsp;
See Also: This AI-Powered Trading Platform Has 5,000+ Users, 27 Pending Patents, and a $43.97M Valuation — <a href="https://www.benzinga.com/money/finally-a-fully-automated-trading-platform-for-individual-investors?">You Can Become an Investor for Just $500.25</a>
Instead of requiring more working hours, these European tech experts say that startups need more funding and resources to be competitive on the world stage. 
"What Europe really needs isn't more hustle-porn it's more aggressive funding," Wernér told CNBC. "With the right level of capital, our startups can hire enough talent to work intensely without breaking themselves."
Still, these experts acknowledge that for many startups, there will be a season of hustle that is necessary to achieve a certain level of success.&nbsp;
"I think there are seasons but I also think that if you are a first-time founder or if your primary goal is basically wealth creation, I'll be very candid, if this is your season, and you're stepping back, then you're not serious about it," Fanbytes co-founder Timothy Armoo told CNBC.
Read Next: Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a>
Image: Imagn Images

BABA

'It's About A Fetishization Of Overwork Rather Than Smart Work,' Why These Tech Leaders Are Pushing Back Against '996 Work Culture'

Prosperity Bancshares's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PB#NYSE">PB</a>) short percent of float has risen 9.5% since its last report. The company recently reported that it has 2.16 million shares sold short, which is 2.65% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.68 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Prosperity Bancshares Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752508882_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Prosperity Bancshares has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Prosperity Bancshares's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Prosperity Bancshares's peer group average for short interest as a percentage of float is 4.32%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

What's Driving the Market Sentiment Around Prosperity Bancshares?

Coterra Energy's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTRA#NYSE">CTRA</a>) short percent of float has risen 4.84% since its last report. The company recently reported that it has 28.80 million shares sold short, which is 4.33% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.44 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Coterra Energy Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752508877_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Coterra Energy has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Coterra Energy's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Coterra Energy's peer group average for short interest as a percentage of float is 8.37%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

CTRA

What Does the Market Think About Coterra Energy?

In the current market session, Kinder Morgan Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMI#NYSE">KMI</a>) stock price is at $27.76, after a 0.29% drop. However, over the past month, the company's stock spiked by 2.29%, and in the past year, by 38.83%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1752508877_0_0.png" alt="Past Year Chart" />

<h3>Kinder Morgan P/E Ratio Analysis in Relation to Industry Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 75.44 in the Oil, Gas &amp; Consumable Fuels industry, Kinder Morgan Inc. has a lower P/E ratio of 24.0. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1752508877_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

Price Over Earnings Overview: Kinder Morgan

Air Lease's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AL#NYSE">AL</a>) short percent of float has risen 24.76% since its last report. The company recently reported that it has 3.02 million shares sold short, which is 3.88% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.23 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Air Lease Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752508872_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Air Lease has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Air Lease's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Air Lease's peer group average for short interest as a percentage of float is 5.15%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Is the Market Bullish or Bearish on Air Lease?

JP Morgan analyst Jessica Fye maintains Incyte (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INCY#NASDAQ">INCY</a>) with a Neutral and lowers the price target from $68 to $67.

INCY

JP Morgan Maintains Neutral on Incyte, Lowers Price Target to $67

Investors with a lot of money to spend have taken a bearish stance on CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with CRWD, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 43 uncommon options trades for CrowdStrike Holdings.
This isn't normal.
The overall sentiment of these big-money traders is split between 30% bullish and 46%, bearish.
Out of all of the special options we uncovered, 12 are puts, for a total amount of $644,602, and 31 are calls, for a total amount of $2,609,403.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $230.0 to $680.0 for CrowdStrike Holdings over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in CrowdStrike Holdings's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to CrowdStrike Holdings's substantial trades, within a strike price spectrum from $230.0 to $680.0 over the preceding 30 days.
<h3>CrowdStrike Holdings Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752508851_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$24.2</td>
<td>$23.5</td>
<td>$24.15</td>
<td>$650.00</td>
<td>$603.7K</td>
<td>76</td>
<td align="right">1</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$9.9</td>
<td>$8.15</td>
<td>$8.3</td>
<td>$470.00</td>
<td>$249.0K</td>
<td>1.0K</td>
<td align="right">63</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>08/29/25</td>
<td>$30.55</td>
<td>$29.3</td>
<td>$29.81</td>
<td>$480.00</td>
<td>$178.8K</td>
<td>8</td>
<td align="right">61</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$42.5</td>
<td>$42.5</td>
<td>$42.5</td>
<td>$460.00</td>
<td>$170.0K</td>
<td>487</td>
<td align="right">44</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/25/25</td>
<td>$13.7</td>
<td>$12.95</td>
<td>$13.4</td>
<td>$477.50</td>
<td>$167.5K</td>
<td>18</td>
<td align="right">131</td>
</tr>
</tbody>
</table>

<h3>About CrowdStrike Holdings</h3>
CrowdStrike is a cloud-based cybersecurity company specializing in next-generation security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform that offers a proverbial single pane of glass for an enterprise to detect and respond to security threats attacking its IT infrastructure. The Texas-based firm was founded in 2011 and went public in 2019.
Having examined the options trading patterns of CrowdStrike Holdings, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is CrowdStrike Holdings Standing Right Now?</h3>
<ul>
<li>With a trading volume of 1,749,700, the price of CRWD is down by -0.56%, reaching $475.75.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 44 days from now.</li>
</ul>
<h3>Expert Opinions on CrowdStrike Holdings</h3>
In the last month, 3 experts released ratings on this stock with an average target price of $518.33.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from CFRA has revised its rating downward to Hold, adjusting the price target to $555. 
&#x2A; Reflecting concerns, an analyst from Piper Sandler lowers its rating to Neutral with a new price target of $505. 
&#x2A; An analyst from Morgan Stanley has revised its rating downward to Equal-Weight, adjusting the price target to $495. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for CrowdStrike Holdings, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Options

CRWD

Looking At CrowdStrike Holdings's Recent Unusual Options Activity

Financial giants have made a conspicuous bearish move on NVIDIA. Our analysis of options history for NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) revealed 270 unusual trades.
Delving into the details, we found 45% of traders were bullish, while 46% showed bearish tendencies. Out of all the trades we spotted, 59 were puts, with a value of $2,999,705, and 211 were calls, valued at $13,716,082.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $10.0 to $205.0 for NVIDIA during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for NVIDIA's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across NVIDIA's significant trades, within a strike price range of $10.0 to $205.0, over the past month.
<h3>NVIDIA Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752508846_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$29.5</td>
<td>$29.35</td>
<td>$29.5</td>
<td>$150.00</td>
<td>$590.0K</td>
<td>48.9K</td>
<td>849</td>
</tr>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$29.4</td>
<td>$29.25</td>
<td>$29.34</td>
<td>$140.00</td>
<td>$205.3K</td>
<td>109.9K</td>
<td>372</td>
</tr>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>07/18/25</td>
<td>$29.95</td>
<td>$29.75</td>
<td>$29.87</td>
<td>$135.00</td>
<td>$188.1K</td>
<td>37.2K</td>
<td>451</td>
</tr>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/25/25</td>
<td>$2.18</td>
<td>$2.17</td>
<td>$2.18</td>
<td>$170.00</td>
<td>$178.2K</td>
<td>26.0K</td>
<td>8.6K</td>
</tr>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$1.49</td>
<td>$1.46</td>
<td>$1.48</td>
<td>$167.50</td>
<td>$165.7K</td>
<td>75.0K</td>
<td>45.6K</td>
</tr>
</tbody>
</table>

<h3>About NVIDIA</h3>
Nvidia is a leading developer of graphics processing units. Traditionally, GPUs were used to enhance the experience on computing platforms, most notably in gaming applications on PCs. GPU use cases have since emerged as important semiconductors used in artificial intelligence. Nvidia not only offers AI GPUs, but also a software platform, Cuda, used for AI model development and training. Nvidia is also expanding its data center networking solutions, helping to tie GPUs together to handle complex workloads.
Having examined the options trading patterns of NVIDIA, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Present Market Standing of NVIDIA</h3>
<ul>
<li>Currently trading with a volume of 77,051,287, the NVDA's price is down by -0.06%, now at $164.82. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 44 days.</li>
</ul>
<h3>What Analysts Are Saying About NVIDIA</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $187.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Oppenheimer has revised its rating downward to Outperform, adjusting the price target to $175. 
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Overweight rating on NVIDIA with a target price of $200. 
&#x2A; In a cautious move, an analyst from Goldman Sachs downgraded its rating to Buy, setting a price target of $185. 
&#x2A; Consistent in their evaluation, an analyst from Mizuho keeps a Outperform rating on NVIDIA with a target price of $185. 
&#x2A; Consistent in their evaluation, an analyst from Citigroup keeps a Buy rating on NVIDIA with a target price of $190. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest NVIDIA options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

NVDA

Unpacking the Latest Options Trading Trends in NVIDIA

Deep-pocketed investors have adopted a bearish approach towards CRISPR Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRSP#NASDAQ">CRSP</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CRSP usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options activities for CRISPR Therapeutics. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 20% leaning bullish and 50% bearish. Among these notable options, 2 are puts, totaling $66,596, and 8 are calls, amounting to $494,260.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $30.0 to $75.0 for CRISPR Therapeutics over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for CRISPR Therapeutics options trades today is 1201.38 with a total volume of 708.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for CRISPR Therapeutics's big money trades within a strike price range of $30.0 to $75.0 over the last 30 days.
<h3>CRISPR Therapeutics Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752508841_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CRSP</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/17/25</td>
<td>$9.1</td>
<td>$8.3</td>
<td>$9.1</td>
<td>$50.00</td>
<td>$182.0K</td>
<td>2.1K</td>
<td align="right">14</td>
</tr>
<tr>
<td>CRSP</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>10/17/25</td>
<td>$9.7</td>
<td>$8.4</td>
<td>$9.1</td>
<td>$50.00</td>
<td>$91.0K</td>
<td>2.1K</td>
<td align="right">314</td>
</tr>
<tr>
<td>CRSP</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>10/17/25</td>
<td>$7.1</td>
<td>$6.5</td>
<td>$6.7</td>
<td>$55.00</td>
<td>$67.0K</td>
<td>448</td>
<td align="right">10</td>
</tr>
<tr>
<td>CRSP</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/17/25</td>
<td>$7.9</td>
<td>$7.2</td>
<td>$7.9</td>
<td>$52.50</td>
<td>$39.5K</td>
<td>864</td>
<td align="right">95</td>
</tr>
<tr>
<td>CRSP</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$4.8</td>
<td>$4.7</td>
<td>$4.8</td>
<td>$60.00</td>
<td>$34.5K</td>
<td>4.3K</td>
<td align="right">0</td>
</tr>
</tbody>
</table>

<h3>About CRISPR Therapeutics</h3>
Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.
Having examined the options trading patterns of CRISPR Therapeutics, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Present Market Standing of CRISPR Therapeutics</h3>
<ul>
<li>With a volume of 1,236,907, the price of CRSP is down -1.9% at $55.72. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 21 days.</li>
</ul>
<h3>What Analysts Are Saying About CRISPR Therapeutics</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $76.6.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Piper Sandler downgraded its action to Overweight with a price target of $105. 
&#x2A; In a cautious move, an analyst from HC Wainwright &amp; Co. downgraded its rating to Buy, setting a price target of $65. 
&#x2A; Consistent in their evaluation, an analyst from Chardan Capital keeps a Buy rating on CRISPR Therapeutics with a target price of $82. 
&#x2A; An analyst from Clear Street downgraded its action to Hold with a price target of $45. 
&#x2A; An analyst from JMP Securities downgraded its action to Market Outperform with a price target of $86. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for CRISPR Therapeutics, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

CRSP

CRISPR Therapeutics's Options: A Look at What the Big Money is Thinking

<a href="https://www.theinformation.com/articles/bytedance-developing-mixed-reality-goggles-challenge-meta" title="https://www.theinformation.com/articles/bytedance-developing-mixed-reality-goggles-challenge-meta">https://www.theinformation.com/articles/bytedance-developing-mixed-reality-goggles-challenge-meta</a>

LUCY

SNAP

VUZI

WIMI

WRBY

'ByteDance Developing Mixed Reality Goggles in Challenge to Meta' -  The Information

Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) has outperformed the market over the past 5 years by 5.72% on an annualized basis producing an average annual return of 19.89%. Currently, Microsoft has a market capitalization of $3.74 trillion. 
Buying $1000 In MSFT: If an investor had bought $1000 of MSFT stock 5 years ago, it would be worth $2,464.74 today based on a price of $502.56 for MSFT at the time of writing.
<h3>Microsoft's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752508816_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MSFT

If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today

Roth Capital analyst Rohit Kulkarni maintains Uber Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) with a Buy and raises the price target from $93 to $110.

UBER

Roth Capital Maintains Buy on Uber Technologies, Raises Price Target to $110

JP Morgan analyst Jessica Fye maintains BioMarin Pharmaceutical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRN#NASDAQ">BMRN</a>) with a Overweight and raises the price target from $108 to $113.

BMRN

JP Morgan Maintains Overweight on BioMarin Pharmaceutical, Raises Price Target to $113

Press Releases

Greenlane Selects Mainstem's B2B Procurement Platform to Compliment its Supply Chain Ecosystem

Management

3WIN Corp. Appoints Craig Snyder as Chief Executive Officer and Director

Pennies on the Rise: HCTI, SWISF, ADHC, NCNA Gain Traction Amid LargeCap Uncertainty – More Stocks Inside

Greenlane and Greentank Technologies Announce U.S. Distribution Agreement

Greenlane Granted Continued Listing from Nasdaq Hearings Panel, Subject to Return to Compliance with Nasdaq Listing Rules

Greenlane and PAX Renew Distribution Agreement

Greenlane Announces Board's Approval of Reverse Stock Split Ratio

Greenlane Bolsters Global Sales Effort with Appointment of Mike Hinson as Executive Vice President of Sales

Greenlane's Leading Wholesale Platform Provides Exclusive Fulfillment of All Safety Strips Tech Corp's. Harm Reduction Solutions Offered via its Direct-to-Consumer Ecommerce Store

Comments

Greenlane Hldgs

Greenlane Hldgs (GNLN) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO